242 results
Page 2 of 13
8-K
EX-99.2
dxjl kn252hhslm3j
4 Nov 21
Caladrius Biosciences Provides Corporate Update and Reports 2021 Third Quarter Financial Results
4:09pm
8-K
EX-99.2
4lw8jms
5 Aug 21
Caladrius Biosciences Reports Second Quarter 2021 Financial Results and Provides Business Update
4:09pm
8-K
EX-10.1
2l4pj6nt1uok5gd2
4 Jun 21
Entry into a Material Definitive Agreement
4:44pm
8-K
EX-99.2
k21zh31 e0
6 May 21
Caladrius Biosciences Reports First Quarter 2021 Financial Results and Provides Business Update
4:06pm
8-K
EX-99.2
5pay qnxlo56bq
25 Feb 21
Caladrius Biosciences Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
4:07pm
8-K
EX-99.1
vhewwge 871r1
29 Jan 21
Regulation FD Disclosure
7:58am
8-K
EX-10.1
v70j4
25 Jan 21
Caladrius Biosciences Announces $25.0 Million Private Placement
4:01pm
8-K
EX-99.1
va80pryb956m3mlbd
11 Jan 21
Regulation FD Disclosure
4:07pm
8-K
EX-99.1
8lc6e28d25ew7at n5
14 Dec 20
Regulation FD Disclosure
8:04am
8-K
EX-10.1
jguswxkdk o0o428vi
10 Jul 20
Entry into a Material Definitive Agreement
4:41pm
8-K
EX-10.1
jepfzji1o6y489pj
26 May 20
Caladrius Biosciences Announces $4.3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
8:02am
8-K
EX-10.1
b2giy 3582hf1aiwx
24 Apr 20
Caladrius Biosciences Announces $5.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
4:02pm
8-K
EX-10.1
ossdze9oily jgy1
14 Mar 19
Caladrius Biosciences Reports 2018 Fourth Quarter and Year End Financial Results
4:18pm